Global Pyrogen Testing Market – A Novel Approach for Detecting Pyrogen Contamination
Pyrogen test is a crucial conducted in advanced healthcare to detect the presence of pyrogene, which is fever-causing organism. Pyrogen can be found in lepoteichoic and ipopolysaccharides acid. Moreover, products contaminated with pyrogenic organism cause harmful effects such as fever in humans.
The global pyrogen testing market size was valued at US$ US$ 689.9 million in 2017, and is expected to exhibit a CAGR of 12.4% over the forecast period (2018 – 2026).
Key players operating in the global pyrogen testing market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar.
Fill the form for an exclusive sample of this report@ https://www.coherentmarketinsights.com/insight/request-sample/243
Growing demand for testing of pyrogen contamination in medical devices and drugs is expected to drive growth of the global pyrogen testing market
Pyrogen testing finds applications in detection of pyrogen contamination in medical devices and pharmaceutical dosage forms. Due to its contamination various diseases such as shock, mutiorgan failure, temperature dysregulation (fever), inflammation, and bodyach can cause.
Increasing research and development activities in medical devices and therapeutic research is expected to drive growth of global pyrogen testing market over the forecast period. For instance, according to United Nations Educational, Scientific, and CUltureal Organizartio (UNESCO), in November 2016, around US$ 1.7 trillion of global expenditure was recorded in research and development of various medical applications. Moreover, increasing approval from regulatory authorities is expected to drive the market growth. For instance, in 2018, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER), approved around 59 novel drugs, compared to 46 approvals of new molecule entities in 2017.
Increasing research and development activities in healthcare sector in North America is expected to boost the market growth in the region
North America holds dominant position in the global pyrogen testing market. This is owing to high prevalence of cardiovascular disease in the region. According to the European Federation of Pharmaceutical Industries and Association (EFPIA) report, in 2018, around US$ 48,111 million and US$ 82,418 million pharmaceutical expenditure was recorded in 2015 and 2016 respectively, in the U.S.
Browse Press Release: https://bit.ly/2Yytn2b
Furthermore, increasing product approvals for new molecule entities (NMEs) by regulatory authorities in this region is expected to propel the market growth in the region during the forecast period. For instance, in 2018, the U.S. Food and Drug Administration (FDA), approved 59 new molecule entities, which enabled new treatment options for patients and advances in healthcare for patients in the U.S.
Moreover, key players in the market are focused on various inorganic growth strategies such as collaboration for development of new kits and reagents used in detection of pyrogen in pharmaceutical products and devices. For instance, in May 2018, Merck collaborated with Solvias to develop PyroMAT System, a new kit for detection of pyrogen.
- Global Pyrogen Testing Market, By Test Type:
- Limulus Amoebocyte Lysate (LAL) Test
- TAL Test
- Monocyte Activation Test (MAT)
- Rabbit Pyrogen Test (RPT)
- Recombinant Factor C Assay (rFC)
- Global Pyrogen Testing Market, By Product Type:
- Global Pyrogen Testing Market, By End User:
- Pharmaceutical and Biotech Companies
- Food and Beverages Companies
Get This Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/243
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: : email@example.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027